Home
About us
Strategy and Business Model
Board of Directors
Management Team
Medical Advisors
Business Development
History
Career
Projects
SpagoPix
Tumorad
Nanomedicine
The EPR-effect
Companion Diagnostics
Publications
Investors
The Share
Owners
General Meetings
Calendar
Financial Reports
Auditor
Presentations
Analyst Coverage
Media
Corporate Profile
Press Releases
News
Image Bank
Contact
- Select -
Home
About us
- Strategy and Business Model
- Board of Directors
- Management Team
- Medical Advisors
- Business Development
- History
- Career
Projects
- SpagoPix
- Tumorad
Nanomedicine
- The EPR-effect
- Companion Diagnostics
Publications
Investors
- The Share
- Owners
- General Meetings
- Calendar
- Financial Reports
- Auditor
- Presentations
- Analyst Coverage
Media
- Corporate Profile
- Press Releases
- News
- Image Bank
Contact
SHARE:
+/-:
0.10
SEK / Bid:
8.40
SEK / Ask:
8.48
SEK / Price:
8.50
SEK / High:
8.70
SEK / Low:
8.24
SEK / Quantity:
97 545
/ Turnover:
822 918
SEK / 2021-01-15 16:25 (CET)
Home
About us
Strategy and Business Model
Board of Directors
Management Team
Medical Advisors
Business Development
History
Career
Projects
SpagoPix
Tumorad
Nanomedicine
The EPR-effect
Companion Diagnostics
Publications
Investors
The Share
Owners
General Meetings
Calendar
Financial Reports
Auditor
Presentations
Analyst Coverage
Media
Corporate Profile
Press Releases
News
Image Bank
Contact
Analyst Coverage
Redeye
Analyst: Ludvig Svensson
News and analyses on Spago Nanomedical
Erik Penser Bank
Analyst: Klas Palin
News and analyses on Spago Nanomedical
Home
About us
Strategy and Business Model
Board of Directors
Management Team
Medical Advisors
Business Development
History
Career
Back
Projects
SpagoPix
Tumorad
Back
Nanomedicine
The EPR-effect
Companion Diagnostics
Back
Publications
Investors
The Share
Owners
General Meetings
Calendar
Financial Reports
Auditor
Presentations
Analyst Coverage
Back
Media
Corporate Profile
Press Releases
News
Image Bank
Back
Contact